0.0780
+0.0010
+(1.30%)
At close: January 31 at 5:21:21 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,597.0000
-18,597.0000
-9,443.0000
-8,572.0000
-4,678.0000
Investing Cash Flow
-177.0000
-177.0000
-409.0000
-66.0000
6,015.0000
Financing Cash Flow
10,759.0000
10,759.0000
6,463.0000
11,976.0000
7,481.0000
End Cash Position
6,814.0000
6,814.0000
14,585.0000
17,886.0000
14,523.0000
Capital Expenditure
-183.0000
-183.0000
-488.0000
-139.0000
-119.0000
Issuance of Capital Stock
12,114.0000
12,114.0000
7,974.0000
9,352.0000
10,576.0000
Issuance of Debt
--
--
--
2,620.0000
--
Repayment of Debt
-1,223.0000
-1,223.0000
-1,513.0000
--
-3,094.0000
Repurchase of Capital Stock
-125.0000
-125.0000
--
--
--
Free Cash Flow
-18,780.0000
-18,780.0000
-9,931.0000
-8,711.0000
-4,797.0000
12/31/2020 - 6/5/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AYJ.HA Valneva SE
2.6900
+10.52%
ALTME.PA TME Pharma N.V.
0.0702
+0.29%
ALNEV.PA Neovacs S.A.
0.2600
-18.75%
ALCOX.PA Nicox S.A.
0.3035
-1.14%
TNG.PA Transgene SA
0.6930
-4.55%
ADOC.PA Adocia SA
5.86
-0.34%
IPH.PA Innate Pharma S.A.
1.8000
+3.09%
NANO.PA Nanobiotix S.A.
3.5000
+2.10%
GNFT.PA Genfit S.A.
3.5750
-2.85%
ATORX.ST Alligator Bioscience AB (publ)
0.0404
+24.31%